Literature DB >> 29888691

External auditory canal cholesteatoma and benign necrotising otitis externa: clinical study of 95 cases in the Capital Region of Denmark.

J Hertz1, C Siim1.   

Abstract

OBJECTIVE: To identify epidemiological and pathophysiological factors, and treatment strategies, in external auditory canal cholesteatoma and benign necrotising otitis externa.
METHODS: A retrospective case study was conducted of patients suffering from external auditory canal cholesteatoma and benign necrotising otitis externa admitted to tertiary hospitals, in the Capital Region of Denmark, over a five-year period.
RESULTS: Eighty-three patients (95 ears) with external auditory canal cholesteatoma or benign necrotising otitis externa were identified. A minimum incidence rate of 0.97 per 100 000 inhabitants per year was demonstrated. Sixty-eight per cent of cases had a history of smoking. Most lesions (74 per cent) were localised in the floor of the ear canal. Treatment time was 3.2 months for patients who had surgery and 6.0 months for those who received conservative treatment.
CONCLUSION: It is suggested that external auditory canal cholesteatoma and benign necrotising otitis externa are in fact the same disease, and therefore the diagnosis of external auditory canal cholesteatoma should be changed to benign necrotising otitis externa. Microangiopathy has a leading role in the aetiology. Surgery should be conducted in most cases.

Entities:  

Keywords:  Cholesteatoma; Diagnosis; Ear Canal; Ear Diseases; History; Otitis Externa; Pathology

Mesh:

Substances:

Year:  2018        PMID: 29888691     DOI: 10.1017/S0022215118000750

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  1 in total

1.  Effects of cigarette smoke on Haemophilus influenzae-induced otitis media in a rat model.

Authors:  Sung-Won Choi; Sunmi Choi; Eun-Jin Kang; Hyun Min Lee; Se-Joon Oh; Il-Woo Lee; Hwan Ho Lee; Soo-Keun Kong
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.